Transcatheter mitral valve repair with the PASCAL device showed high rates of survival and freedom from heart failure rehospitalization at 2 years in the single-arm, safety and efficacy CLASP study.
Edwards Lifesciences Corp.’s catheter-based heart valve clips infringe a patent for a prosthetic support used to repair leaky ...
SAN FRANCISCO, Oct. 26, 2023 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW) announced one-year results from CLASP IID, the first randomized controlled trial that directly compares two ...
IRVINE, Calif.--(BUSINESS WIRE)-- Edwards Lifesciences Corporation (EW) today announced the company’s SAPIEN M3 mitral valve replacement system received CE Mark for the transcatheter treatment of ...
Evoque Tricuspid Replacement in Patient With Multiple Leads Using Intracardiac Echocardiography Alone With the "Back-Bend" Technique Receive the the latest news, research, and presentations from major ...
Singapore, 23 June 2025 – For 77-year-old Mrs Ong, climbing stairs or walking a short distance to the market had become increasingly difficult due to her leaky heart valve. Today, she moves about ...
TCT 1857: Successful Coil Embolization of a Large Coronary Pseudoaneurysm After Repeated Drug‑Coated Balloon Angioplasty: A Complex Case Report Receive the the latest news, research, and presentations ...
Edwards Lifesciences (NYSE: EW) today announced the company’s SAPIEN M3 mitral valve replacement system is the first transcatheter therapy utilizing a transseptal approach to receive U.S. Food and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback